Telomere shortening in uterine leiomyomas

被引:27
作者
Bonatz, G
Frahm, SO
Andreas, S
Heidorn, K
Jonat, W
Parwaresch, R
机构
[1] Univ Kiel, Dept Obstet & Gynecol, D-24105 Kiel, Germany
[2] Univ Kiel, Dept Pathol, D-24105 Kiel, Germany
关键词
uterine leiomyomas; mean telomere length; clonality; tumor growth; phosphoglycerokinase gene;
D O I
10.1016/S0002-9378(98)70050-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To gain a better understanding of proliferation control mechanisms in a common benign tumor, we investigated the mean telomere length and the clonality of uterine leiomyomas. STUDY DESIGN: Deoxyribonucleic acid from uterine leiomyomas and from the adjacent normal myometrium of 51 patients (total number of uterine leiomyomas 107, 28 patients with single leiomyoma, 23 patients with multiple leiomyomas ranging from 2 to 8 myoma nodules per case) was hybridized to a telomeric oligonucleotide probe by Southern blot and chemiluminescent detection. The mean telomere length was evaluated by densitometry. Clonality was assessed with use of the phosphoglycerokinase gene polymorphism. RESULTS: The mean telomere length was significantly shorter in uterine leiomyomas (median 7950 bp, interquartile range 7261 to 8372 bp) than in normal myometrium (median 9688 bp, interquartile range 8528 to 10535 bp) (P <.001). There was no correlation between tumor size and telomere attrition. Multiple uterine leiomyomas were found to have an independent clonal origin. CONCLUSIONS: Telomere attrition in uterine leiomyomas reflects enhanced proliferation activity in the course of tumor evolution. The basic telomere lengths differ in the myocytes from which the uterine leiomyomas originate, probably explaining the lack of correlation between telomere attrition and tumor size.
引用
收藏
页码:591 / 596
页数:6
相关论文
共 26 条
[11]   NONRANDOM CYTOGENETIC CHANGES IN LEIOMYOMAS OF THE FEMALE GENITOURINARY TRACT - A REPORT OF 35 CASES [J].
KIECHLESCHWARZ, M ;
SREEKANTAIAH, C ;
BERGER, CS ;
PEDRON, S ;
MEDCHILL, MT ;
SURTI, U ;
SANDBERG, AA .
CANCER GENETICS AND CYTOGENETICS, 1991, 53 (01) :125-136
[12]   SPECIFIC ASSOCIATION OF HUMAN TELOMERASE ACTIVITY WITH IMMORTAL CELLS AND CANCER [J].
KIM, NW ;
PIATYSZEK, MA ;
PROWSE, KR ;
HARLEY, CB ;
WEST, MD ;
HO, PLC ;
COVIELLO, GM ;
WRIGHT, WE ;
WEINRICH, SL ;
SHAY, JW .
SCIENCE, 1994, 266 (5193) :2011-2015
[13]   TELOMERE SHORTENING IN CHRONIC LIVER-DISEASES [J].
KITADA, T ;
SEKI, S ;
KAWAKITA, N ;
KUROKI, T ;
MONNA, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 211 (01) :33-39
[14]   TELOMERE END-REPLICATION PROBLEM AND CELL AGING [J].
LEVY, MZ ;
ALLSOPP, RC ;
FUTCHER, AB ;
GREIDER, CW ;
HARLEY, CB .
JOURNAL OF MOLECULAR BIOLOGY, 1992, 225 (04) :951-960
[15]   INVIVO LOSS OF TELOMERIC REPEATS WITH AGE IN HUMANS [J].
LINDSEY, J ;
MCGILL, NI ;
LINDSEY, LA ;
GREEN, DK ;
COOKE, HJ .
MUTATION RESEARCH, 1991, 256 (01) :45-48
[16]   CHROMOSOMAL PATTERNS IN HUMAN BENIGN UTERINE LEIOMYOMAS [J].
MARK, J ;
HAVEL, G ;
GREPP, C ;
DAHLENFORS, R ;
WEDELL, B .
CANCER GENETICS AND CYTOGENETICS, 1990, 44 (01) :1-13
[17]  
MARSHAL RD, 1994, GENE CHROMOSOME CANC, V11, P1
[18]  
NGOC MH, 1991, ARCH ANAT CYTOL PATH, V39, P94
[19]   UTERINE LEIOMYOMA CYTOGENETICS [J].
NILBERT, M ;
HEIM, S .
GENES CHROMOSOMES & CANCER, 1990, 2 (01) :3-13
[20]  
REIN MS, 1991, OBSTET GYNECOL, V77, P923